BioSpace News Archive

Business

Molecular Templates Strengthens Management Team with Appointment of Adam Cutler as Chief Financial Officer

Mr. Cutler will report to the CEO and will be responsible for all corporate finance, accounting, and investor relations activities.

November 15, 2017

·

7 min read

Business

Cesca Therapeutics Announces Financial Results for the Three Months Ended September 30, 2017 and Provides Corporate Update

Conference Call to be Held at 4:30 p.m. EST (1:30 p.m. PST).

November 15, 2017

·

9 min read

Business

Asterias Biotherapeutics Reports Third Quarter Financial Results and Recent Developments

As of September 30, 2017, the combined total of cash, cash equivalents, and available-for-sale securities totaled $20.7 million.

November 15, 2017

·

11 min read

Business

aTyr Pharma Announces Third Quarter 2017 Operating Results and Provides Corporate Update

Research and development expenses were $7.1 million and $10.4 million for the three months ended September 30, 2017 and 2016, respectively. T

November 15, 2017

·

8 min read

Pharm Country

Amarin: Real World Data Analysis Shows That Persistent Hypertriglyceridemia Despite Statin Therapy is Associated With Cardiovascular Risk

This analysis of RWE is separate from and independent of the RWE analysis referenced in Amarin’s press release on November 12, 2017.

November 15, 2017

·

9 min read

CIRCULOGENE Introduces Single-Tube, Blood-Based Microsatellite Instability (MSI) Biomarker Testing for Multiple Cancers

The advanced immunotherapy testing is immediately available to oncologists and pathologists, enabling them to identify patients eligible for treatment with Keytruda (pembrolizumab) across multiple cancer types, or Opdivo (nivolumab) for colorectal cancer.

November 15, 2017

·

4 min read

Pharm Country

ADMA Biologics Further Enhances Intellectual Property Portfolio Through Newly Issued U.S. Patent for Immunotherapeutic Compositions

The term of the issued patent extends to January 2035.

November 15, 2017

·

7 min read

Biotech Beach

Cytori Reminds Stockholders That Rights Offering Expires on Tuesday, November 21

Rights holders will need to exercise their subscription rights prior to that date and time.

November 15, 2017

·

6 min read

Business

MEDITE Cancer Diagnostics Appoints Joel Kanter To Its Board as an Independent Director

Mr. Kanter has more than 30 years of experience in the financial services industry.

November 15, 2017

·

4 min read

Drug Development

Preclinical Studies with MyoKardia’s Mavacamten Demonstrate Evidence of Reduced Contractility and Improved Left Ventricular Compliance

Data from MyoKardia’s in vivo study demonstrated that treatment with mavacamten improved myocardial compliance while preserving systemic pressures.

November 15, 2017

·

4 min read